New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting |
| |
| Authors: | R. Rondanin G. Lettini P. Oliva R. Baruchello C. Costantini C. Trapella D. Simoni T. Bernardi L. Sisinni M. Pietrafesa G. Ponterini M.P. Costi T. Vignudelli R. Luciani D.S. Matassa F. Esposito M. Landriscina |
| |
| Affiliation: | 1. Dep. of Chemical and Pharmaceutical Sciences, University of Ferrara, Italy;2. Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture, Italy;3. Dep. of Life Sciences, University of Modena and Reggio Emilia, Italy;4. Dep. of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Italy;5. Dep. of Medical and Surgical Sciences, University of Foggia, Italy |
| |
| Abstract: | TRAP1 (Hsp75) is the mitochondrial paralog of the Hsp90 molecular chaperone family. Due to structural similarity among Hsp90 chaperones, a potential strategy to induce apoptosis through mitochondrial TRAP1 ATPase inhibition has been envisaged and a series of compounds has been developed by binding the simple pharmacophoric core of known Hsp90 inhibitors with various appendages bearing a permanent cationic head, or a basic group highly ionizable at physiologic pH. Cationic appendages were selected as vehicles to deliver drugs to mitochondria. Indeed, masses of new derivatives were evidenced to accumulate in the mitochondrial fraction from colon carcinoma cells and a compound in the series, with a guanidine appendage, demonstrated good activity in inhibiting recombinant TRAP1 ATPase and cell growth and in inducing apoptotic cell death in colon carcinoma cells. |
| |
| Keywords: | TRAP1 inhibitors Mitochondrial targeting Anticancer activity Lipophilic cations Apoptosis |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
